Procter & Gamble (PG) Paul Gama Sells 3,396 Shares

What Happened
Paul Gama, Procter & Gamble's Health Care CEO, reported a sale of 3,396 shares on 2026-08-20. The shares were sold at $143.79 per share for gross proceeds of approximately $488,311. The filing notes the shares were sold to cover taxes on a stock award, a routine tax-withholding transaction rather than a directional investment bet.

Key Details

• Transaction date and price: 2026-08-20, 3,396 shares at $143.79 each.
• Gross proceeds: about $488,311.
• Transaction type: Sale (reported as open market or private sale).
• Footnote: F1 — "Shares sold to cover taxes on Stock Award" (tax withholding).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing date: 2026-08-24 (four days after the transaction); this may be outside the typical 2-business-day Form 4 reporting window.

Context
Sales to cover tax withholding on awards are common and usually reflect administrative needs, not a personal view on the company. For retail investors, purchases are generally more informative about insider sentiment than routine tax-related sales. If timely reporting is a concern, note the filing date relative to the transaction date may indicate a late filing.